|
Name |
Penitrem C
|
Molecular Formula | C37H44ClNO4 | |
IUPAC Name* |
(1S,2R,5S,8R,9R,11R,14R,15S,24S,26S,27S)-20-chloro-14,15,32,32-tetramethyl-23-methylidene-9-prop-1-en-2-yl-10,31-dioxa-17-azanonacyclo[24.4.2.02,15.05,14.06,11.016,30.018,29.021,28.024,27]dotriaconta-6,16(30),18,20,28-pentaene-5,8-diol
|
|
SMILES |
CC(=C)[C@@H]1[C@@H](C=C2[C@H](O1)CC[C@]3([C@]2(CC[C@@H]4[C@@]3(C5=C6[C@H]4OC([C@H]7C[C@H]8[C@@H]7C9=C6C(=CC(=C9CC8=C)Cl)N5)(C)C)C)O)C)O
|
|
InChI |
InChI=1S/C37H44ClNO4/c1-16(2)31-25(40)14-21-26(42-31)9-10-35(6)36(7)20(8-11-37(21,35)41)32-30-29-24(39-33(30)36)15-23(38)19-12-17(3)18-13-22(27(18)28(19)29)34(4,5)43-32/h14-15,18,20,22,25-27,31-32,39-41H,1,3,8-13H2,2,4-7H3/t18-,20+,22+,25-,26-,27+,31-,32+,35-,36-,37-/m1/s1
|
|
InChIKey |
BVVRIERIEDMORG-AKDSLBMVSA-N
|
|
Synonyms |
5GTV3VH5D6; Penitrem C; 7,8-(Epoxymethano)-4bH-1-benzopyrano(5',6':6,7)indeno(1,2-b)cyclobuta(5,6)benz(1,2-e)indole-3,4b-diol, 12-chloro-2,3,5,6,6a,7,7d,8,9,9a,10,11,14,14b,14c,15,16,16a-octadecahydro-14b,14c,17,17-tetramethyl-10-methylene-2-(1-methylethenyl)-, (2R,3R,4bR,6aR,7S,7dS,8S,9aS,14bS,14cR,16aS)-; 37318-84-6; TREMORTIN C; UNII-5GTV3VH5D6
|
|
CAS | 37318-84-6 | |
PubChem CID | 133082328 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 602.2 | ALogp: | 5.0 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 74.7 | Aromatic Rings: | 9 |
Heavy Atoms: | 43 | QED Weighted: | 0.298 |
Caco-2 Permeability: | -5.358 | MDCK Permeability: | 0.00001050 |
Pgp-inhibitor: | 0.99 | Pgp-substrate: | 0.788 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.87 |
30% Bioavailability (F30%): | 0.116 |
Blood-Brain-Barrier Penetration (BBB): | 0.837 | Plasma Protein Binding (PPB): | 91.99% |
Volume Distribution (VD): | 2.506 | Fu: | 3.58% |
CYP1A2-inhibitor: | 0.031 | CYP1A2-substrate: | 0.958 |
CYP2C19-inhibitor: | 0.397 | CYP2C19-substrate: | 0.833 |
CYP2C9-inhibitor: | 0.314 | CYP2C9-substrate: | 0.106 |
CYP2D6-inhibitor: | 0.126 | CYP2D6-substrate: | 0.185 |
CYP3A4-inhibitor: | 0.709 | CYP3A4-substrate: | 0.92 |
Clearance (CL): | 5.033 | Half-life (T1/2): | 0.005 |
hERG Blockers: | 0.854 | Human Hepatotoxicity (H-HT): | 0.396 |
Drug-inuced Liver Injury (DILI): | 0.804 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0.994 | Maximum Recommended Daily Dose: | 0.984 |
Skin Sensitization: | 0.106 | Carcinogencity: | 0.672 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.988 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001486 | 0.829 | D06AEO | 0.267 | ||||
ENC001507 | 0.734 | D04GJN | 0.230 | ||||
ENC001499 | 0.615 | D0I2SD | 0.230 | ||||
ENC001891 | 0.578 | D0P0HT | 0.224 | ||||
ENC003330 | 0.567 | D0Y2YP | 0.223 | ||||
ENC003329 | 0.529 | D06IIB | 0.223 | ||||
ENC001508 | 0.497 | D0L2LS | 0.219 | ||||
ENC005404 | 0.450 | D04SFH | 0.214 | ||||
ENC003830 | 0.448 | D02JNM | 0.211 | ||||
ENC003833 | 0.438 | D0W2EK | 0.210 |